MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0092214
Synac Pharmaceuticals Private Limited
Synac Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.79 Cr
▲ 311% YoY
Net profit · FY 2025
₹58.71 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹6.51 Cr
EBITDA margin 23.4%
Authorised capital
₹14.4 Lakh
Registered with MCA
Paid-up capital
₹14.4 Lakh
Issued & subscribed
Open charges
₹35.75 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
72
Provident fund records
About Synac Pharmaceuticals Private Limited
Data last updated:
Synac Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Emnar Pharma Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG2021PTC152637. Its GSTIN is 37ABGCS3224C1ZN (Andhra Pradesh).
The company has an authorised share capital of ₹14.4 Lakh and a paid-up capital of ₹14.4 Lakh. It is led by directors including Nalla Hymavathi and Nalla Surya Prakash Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.79 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹58.71 Lakh (net margin 2.1%) and EBITDA of ₹6.51 Cr (EBITDA margin 23.4%).
The company has about 72 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹35.75 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Synac Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0092214).
Company details
CIN U24231TG2021PTC152637
Registration Number 152637
Incorporation Date 29 June 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Emnar Pharma Private Limited
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0092214
Recognitions & Rankings of Synac Pharmaceuticals
Contact details
Synac Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.8 – 2 – 293/82/J – III/304 – O. Plot No.304, 3rd Floor Road No.78, Hyderabad, Telangana, India – 500033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synac Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Synac Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Synac Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synac Pharmaceuticals Private Limited, buy the company report.
Financials of Synac Pharmaceuticals Private Limited
FY 2025 filings availableSynac Pharmaceuticals Private Limited reported revenue of ₹27.79 Cr (up 311% YoY) for FY 2025.
Revenue · FY 2025
₹27.79 Cr ▲ 311%
Net profit · FY 2025
₹58.71 Lakh margin 2.1%
EBITDA · FY 2025
₹6.51 Cr margin 23.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 311%
EBITDA CAGR growth
1 year
▲ 543%
Revenue rose 311% in the latest year. EBITDA rose 543% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹6.51 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹58.71 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 23.4% | |||
| Net Profit Margin | 2.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Synac Pharmaceuticals Private Limited, buy the company report.
Board of directors of Synac Pharmaceuticals Private Limited
Synac Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nalla Hymavathi | Director | 29 Jun 2021 | 5 Years 3 Months | Current |
| Nalla Surya Prakash Rao | Director | 29 Jun 2021 | 5 Years 3 Months | Current |
| Mundla Maha Vishnu Also directs: Pista Motor Raceway LLP, Ceph Lifesciences Private Limited, Emmennar Pharma Containers Private Limited and 5 more | Director | 29 Jun 2021 | 5 Years 3 Months | Current |
Peer comparison
Synac Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inven Pharmaceuticals Private Limited | ₹27.99 Cr (FY 2025) | -6.0% | Indore, Madhya Pradesh, India | |||
| Shreepati Pharmaceuticals Pvt Ltd | ₹27.91 Cr (FY 2025) | 7.0% | Indore, M.P, Madhya Pradesh, India | |||
| Sellwell Pharmaceuticals Limited | ₹27.85 Cr (FY 2024) | -21.0% | Madhya Pradesh, India | |||
| Synac Pharmaceuticals Private Limitedthis company | ₹27.79 Cr (FY 2025) | ₹58.71 Lakh | 2.1% | 311.0% | 72 | Hyderabad, Telangana, India |
| Lifesticks Pharmaceuticals Private Limited | ₹27.68 Cr (FY 2025) | 196.0% | Roorkee, Uttarakhand, India | |||
| Jips Pharmaceuticals Private Limited | ₹27.63 Cr (FY 2023) | 19.0% | Chandigarh, India | |||
| Cirex Pharmaceuticals Private Limited | ₹27.51 Cr (FY 2025) | 487.0% | Hyderabad, Telangana, India | |||
| Sun Moon Pharmaceuticals Private Limited | ₹27.19 Cr (FY 2025) | 48.0% | Boisar, Maharashtra, India |
To see the full peer comparison of Synac Pharmaceuticals Private Limited, buy the company report.
Auditor
Synac Pharmaceuticals Private Limited is audited by Venkatappaiah & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Venkatappaiah & Co. | FY 2023 | 004617S |
Shareholding
The shareholding of Synac Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Synac Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹35.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2025 | 101055040 | Others | ₹75 Lakh | Open | |
| 03 Feb 2023 | 100689812 | Others | ₹35 Cr | Open |
To see the full charge records of Synac Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Synac Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Synac Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
To see the full case history of Synac Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synac Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Synac Pharmaceuticals Private Limited has a workforce of 72 employees on its EPFO records as of Mar 31, 2024, across 2 active EPFO establishments.
Employee count
72
Active EPFO establishments
2
Employee growth
166.67%
GST
Synac Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37ABGCS3224C1ZN | Andhra Pradesh | Active | 01 Nov 2021 |
To see the full GST registrations and return filing status of Synac Pharmaceuticals Private Limited, buy the company report.
Recent activity
Synac Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Mundla Maha Vishnu was appointed as Director on 29 Jun 2021.
AGM
Synac Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Synac Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 75.00 Lakh with Charge ID 101055040 was registered on 31 Jan 2025.
Charges
A charge with Others of Rs. 3,500.00 Lakh registered on 03 Feb 2023 with Charge ID 100689812 was modified on 10 Apr 2024.
Charges
A charge with Others amounted to Rs. 3,500.00 Lakh with Charge ID 100689812 was registered on 03 Feb 2023.
Appointed
Mundla Maha Vishnu was appointed as Director.
Appointed
Nalla Hymavathi was appointed as Director.
Appointed
Nalla Surya Prakash Rao was appointed as Director.
Incorporation
29 Jun 2021
Synac Pharmaceuticals Private Limited was registered on 29 Jun 2021 with Roc Hyderabad & aged 5 years 3 months as per MCA records.
Frequently asked questions
Synac Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 June 2021 (5+ years old) and is registered under CIN U24231TG2021PTC152637.
Synac Pharmaceuticals has 3 current directors:
- Nalla Hymavathi - Director
- Nalla Surya Prakash Rao - Director
- Mundla Maha Vishnu - Director
The latest financial statements of Synac Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Synac Pharmaceuticals is 37ABGCS3224C1ZN, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Synac Pharmaceuticals is U24231TG2021PTC152637. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synac Pharmaceuticals has 1 court case on record: 1 filed by the company.
Synac Pharmaceuticals was incorporated on 29 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Synac Pharmaceuticals by revenue are Inven Pharmaceuticals Private Limited, Shreepati Pharmaceuticals Pvt Ltd, Sellwell Pharmaceuticals Limited, Lifesticks Pharmaceuticals Private Limited, Jips Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mundla Maha Vishnu was appointed as Director on 29 Jun 2021. Nalla Hymavathi was appointed as Director on 29 Jun 2021. Nalla Surya Prakash Rao was appointed as Director on 29 Jun 2021.
Yes, Synac Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0092214).
The registered office of Synac Pharmaceuticals is at H.No.8 – 2 – 29382J – III304 – O. Plot No.304, 3rd Floor Road No.78, Hyderabad, Telangana, India – 500033.